Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of FRONTEO, Inc.. A complete text table follows the diagram.
Legal-tech AI supplied 32% of revenue, while Life Science AI became the strategic core but remained loss-making during heavy R&D investment.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| AI drug discovery | 1 | 186M | 5.5% of reported total |
| AI medical devices | 1 | 88M | 2.6% of reported total |
| BI & compliance support | 1 | 609M | 18.0% of reported total |
| Economic security | 1 | 235M | 7.0% of reported total |
| Legal-tech AI | 1 | 1.1B | 32.3% of reported total |
| BI professional support | 1 | 95.6M | 2.8% of reported total |
| Alnetz manufacturing DX | 1 | 1.1B | 31.7% of reported total |
| Other & rounding | 1 | 0 | 0.0% of reported total |
| Revenue | 2 | 3.4B | JPY3.375B six-month AI and risk-management revenue |
| KIBIT-powered service portfolio | 3 | 3.4B | Life-science AI, risk management and manufacturing DX built around specialized natural-language AI |
| Other & rounding | 3 | 0 | Service-line amounts are disclosed in rounded thousands of yen and reconcile to the exact external-revenue total with a JPY3K residual. |
| From | To | Value |
|---|---|---|
| AI drug discovery | Revenue | 186M |
| AI medical devices | Revenue | 88M |
| BI & compliance support | Revenue | 609M |
| Economic security | Revenue | 235M |
| Legal-tech AI | Revenue | 1.1B |
| BI professional support | Revenue | 95.6M |
| Alnetz manufacturing DX | Revenue | 1.1B |
| Other & rounding | Revenue | 0 |
| Revenue | KIBIT-powered service portfolio | 3.4B |
| Revenue | Other & rounding | 0 |